Assessment and Quantification of Crystal-Induced Lysosomal Damage
Abstract
Lysosomes are organelles that degrade endocytosed, phagocytosed, or autophagocytosed materials. Lysosomal degradation of engulfed material is a highly controlled mechanism, which is vital in the control of infection, recycling of cellular organelles, and the breakdown of larger material. Following ingestion, lysosomes acidify and mature, leading to the activation of a range of proteolytic enzymes. Lysosomes are considered stable organelles that separate their highly hydrolytic enzymes from the cytosol to prevent digestion of self-molecules and host cell damage. Some substances, mostly of a particulate or aggregated nature, are able to damage lysosomes. Lysosomal damage and rupture, with subsequent release of lysosomal content into the cytosol can have dramatic consequences for the cell, such as the induction of cell death or activation of the NLRP3 inflammasome. In this chapter, we provide methods for the induction, assessment, and quantification of lysosomal damage by flow cytometry and confocal microscopy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
OxLDL primes and activates the NLRP3 inflammasome in macrophages in mouse models of atherosclerosis: it primes via the CD36-TLR4-TLR6 complex and, after lysosomal transport, activates via cholesterol crystallization and lysosomal damage.
“OxLDL has been shown both to prime and to activate the NLRP3 inflammasome in macrophages in mouse models of atherosclerosis: first, oxLDL primes the NLRP3 inflammasome by binding to the CD36–TLR4–TLR6 signalling complex on the macrophage surface and, then, after having been transported to lysosomes, the oxLDL activates the NLRP3 inflammasome via induction of cholesterol crystallization and ensuing”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [71]
Cites
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · see citing works
Self-citationHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065 · see citing works
Self-citationThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441 · see citing works
Self-citationThiele, D. L., & Lipsky, P. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.83 · Cited by 264 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Franklin, B. S., Bossaller, L., De Nardo, D., Ratter, J. M., Stutz, A., Engels, G., Brenker, C., Nordhoff, M., Mirandola, S. R., Al-Amoudi, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2913 · Cited by 773 · see citing works
Self-citationHadri, K. E., Smith, R., Duplus, E., & Amri, C. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010077 · Cited by 70 · see citing works
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
Sirtori, C. R., Ruscica, M., Calabresi, L., Chiesa, G., Giovannoni, R., & Badimón, J. J. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1694695 · Cited by 41 · see citing works
Labzin, L. I., Bottermann, M., Rodríguez-Silvestre, P., Foss, S., Andersen, J. T., Vaysburd, M., Clift, D., & James, L. C. (2019) · The EMBO Journal · doi:10.15252/embj.2018101365 · Cited by 40 · see citing works
Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall
Öörni, K., Lehti, S., Sjövall, P., & Kovanen, P. T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530094819 · Cited by 28 · see citing works
Formation and Cellular Impact of Cholesterol Crystals in Health and Disease
Baumer, Y., McCurdy, S., & Boisvert, W. A. (2021) · Advanced Biology · doi:10.1002/adbi.202100638 · Cited by 23 · see citing works
Li, T., Zehner, M., He, J., Próchnicki, T., Horvath, G. L., Latz, E., Burgdorf, S., & Takeoka, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s202379 · Cited by 22 · see citing works
Self-citationEfferocytosis and inflammation: a bibliometric and systematic analysis
Cao, X., Li, F., Xie, X. S., Ling, G., Tang, X., He, W., Tian, J., & Ge, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1498503 · Cited by 7 · see citing works
Gagné, F. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5265071 · Cited by 4 · see citing works
ApoE-Knockout Mice: What are New Achievements of this Model of Atherosclerosis?
Lorkowska-Zawicka, B., & Jawień, J. (2021) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2021.05.0737
Mandinov, L., & Learn, C. A. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm52626
- Authors
- Duewell, P., & Latz, E.
- Affiliations
- LMU Klinikum (DE)
- University of Bonn (DE)
- Venue
- Methods in Molecular Biology
- Publisher
- Humana Press
- Published
- 2013
- Volume
- 1040
- Pages
- 19-27
- ISSN
- 1064-3745 (ISSN-L)
- 1940-6029
- OpenAlex
- W124277487
- Cited by
- 12
- References
- 4
- Citations by year
- 2026: 1 · 2025: 2 · 2021: 3 · 2019: 4 · 2018: 1 · 2014: 1
- FWCI
- 1.36
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Methods in molecular biology (publishedVersion)
- PubMed (publishedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- lysosomal damage, lysosomal rupture, NLRP3 inflammasome, cell death, lysosomal acidification, flow cytometry, confocal microscopy, lysosomal degradation
- MeSH terms
- Animals, Biological Transport, Crystallins, Flow Cytometry, Lysosomes, Macrophages, Microscopy, Confocal, Liquid Crystals, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review